• ホーム
  • ENGLISH
  • R&D
  • The development of novel biomarkers stratifying
    cancer patients based on comprehensive understanding of
    cancer immunity with immunomonitoring strategies

The development of novel biomarkers stratifying<br /> cancer patients based on comprehensive understanding of<br /> cancer immunity with immunomonitoring strategies Research and Development

The development of novel biomarkers stratifying
cancer patients based on comprehensive understanding of
cancer immunity with immunomonitoring strategies

Business Summary

This project identifies novel markers stratifying cancer patients by analyzing the peripheral blood samples that can be analyzed with minimally invasiveness chronologically, and clarifies the biological and pathological significance of the markers through cancer tissue immunity assessment. Furthermore, we aim to develop a new cancer immunotherapy diagnostic system by creating an algorithm to optimize the treatment of individual patients through database construction and analysis.

Contents

  • Mathematical understanding of the entire immune system by analyzing the peripheral blood immune cells in cancer patients
  • Elucidation of cancer immune response regulation mechanism based on tumor microenvironment analysis by local cancer immunity assessment
  • Development of analytical AI tools and construction of database to explore novel biomarkers stratifying cancer patients after by the systematic data showing cancer immune status founded from research (1) and (2)
  • Development and validation of diagnostic equipment for practical use of patient stratifying markers